Research reveals that a new diagnosis of type 2 diabetes significantly increases the risk of certain obesity-related cancers, independent of BMI.

Research reveals that a new diagnosis of type 2 diabetes significantly increases the risk of certain obesity-related cancers, independent of BMI.

Eli Lilly and Company launched Mounjaro in single─dose vial presentation following the marketing authorization from the Central Drugs Standard...

Eli Lilly and Company launched Mounjaro in single─dose vial presentation following the marketing authorization from the Central Drugs Standard...

Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...

Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...

A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.

Under the Supervision of Emirates Hospitals and in Collaboration with Novo Nordisk As part of a dedicated health awareness campaign titled “From...

Under the Supervision of Emirates Hospitals and in Collaboration with Novo Nordisk As part of a dedicated health awareness campaign titled “From...

Diagnosis determines the effectiveness of treatment and guides prevention strategies, according to Prof Oriel Thekisoe, a molecular biologist, at his...